A great antibody is not necessarily a great drug Antibody discovery is becoming less about finding the strongest binder and more about finding molecules that can survive the journey to the clinic. Written byBree Foster, PhD

A great antibody is not necessarily a great drug Antibody discovery is becoming less about finding the strongest binder and more about finding molecules that can survive the journey to the clinic. Written byBree Foster, PhD For years, antibody discovery has largely revolved around one question: Can the molecule bind its target and produce the desired biological effect? Increasingly, researchers are asking another question much earlier in the process: Can that antibody actually become a drug? Maria Gonzalez-Pajuelo, cofounder and Executive Vice President of Technology and Scientific Office at FairJourney Bio, told DDN that developability has become a much more important consideration during antibody discovery, rather than an issue left until later-stage development. https://www.drugdiscoverynews.com/a-great-antibody-is-not-necessarily-a-great-drug-17548